Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Director/PDMR Shareholding

27 Mar 2019 07:00

RNS Number : 0951U
LiDCO Group Plc
27 March 2019
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Director/ PDMR Shareholding

LiDCO (AIM: LID), the hemodynamic monitoring company, announces the following share purchases made by employees on 26 March 2019.

· Mr Timothy Hall, Chief Financial Officer, purchased 100,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.40p per Ordinary Share. Following the above transaction, Mr Hall's total beneficial holding is 100,000 Ordinary Shares, representing 0.041% of the Company's issued share capital.

· Mr Peter Grant, Chairman, purchased 200,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.50p per Ordinary Share. Following the above transaction, Mr Grant's total beneficial holding is 700,000 Ordinary Shares, representing 0.287% of the Company's issued share capital.

· Mr Phil Cooper, Non-executive Director, purchased 100,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.40p per Ordinary Share. Following the above transaction, Mr Cooper's total beneficial holding is 1,766.667 Ordinary Shares, representing 0.724% of the Company's issued share capital.

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Timothy Hall

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.40 pence per share

100,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.40 pence per share

100,000

£4,400

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Peter Grant

2.

Reason for the notification

a)

Position/status:

Chairman

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.50 pence per share

200,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Aggregate transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.50 pence per share

200,000

£9.000

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Phil Cooper

2.

Reason for the notification

a)

Position/status:

Non-executive Director

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.40 pence per share

100,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.40 pence per share

100,000

£4,400

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

 

For further information, please contact:

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tim Hall (CFO)

Tel: +44 (0)20 7749 1500

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Hannah Boros (Corporate Finance)

Andrew Burdis (ECM)

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07876 741 001

Lianne Cawthorne (Media Relations)

Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNSWRKRAOUAR
Date   Source Headline
29th Mar 20167:00 amRNSRegulatory approval in China
24th Mar 20167:00 amRNSMaster distribution agreement & other distributors
15th Mar 20167:00 amRNSLaunching the new LiDCOunity at ISICEM Brussels
4th Mar 20164:31 pmRNSHolding(s) in Company
2nd Mar 20165:06 pmRNSBlock Listing Review
8th Feb 20167:00 amRNSTrading update
2nd Feb 20163:52 pmRNSHolding(s) in Company
23rd Nov 20157:00 amRNSMaster distribution agreement
16th Nov 20154:35 pmRNSDirector's Dealing
13th Oct 20158:30 amRNSUS purchasing agreement with US hospitals group
13th Oct 20157:00 amRNSHalf Yearly Report
23rd Sep 201510:03 amRNSNotice of Results
2nd Sep 20157:00 amRNSTrading update and notice of results
17th Aug 20157:00 amRNSFormal appointment of Chief Executive Officer
31st Jul 20157:00 amRNSBlock Listing Review
15th Jun 20152:27 pmRNSBoard appointment and grant of share options
11th Jun 20157:00 amRNSJapan reimbursement for LiDCOrapidv2 disposables
13th May 201511:45 amRNSResult of AGM
6th May 20157:01 amRNSCEO and Board Appointment
5th May 20151:32 pmRNSPosting of Annual Report & Notice of AGM
23rd Apr 20157:00 amRNSLiDCO data presented at London Forum
14th Apr 20157:00 amRNSHolding in Company
1st Apr 201512:49 pmRNSDirector/PDMR Shareholding
31st Mar 20157:01 amRNSLIDCOrapid v2 cleared for sale in Japan
31st Mar 20157:00 amRNSFinal Results
17th Mar 20157:00 amRNSShowcasing Portable LiDCO Stand System at ISICEM
10th Mar 20157:03 amRNSNotice of Results
2nd Mar 20156:14 pmRNSHolding(s) in Company
17th Feb 20157:00 amRNSFurther clinical support for LiDCOrapid
12th Feb 20157:00 amRNSTrading update and notice of results
30th Jan 201512:20 pmRNSBlock listing review
17th Dec 20142:39 pmRNSHolding(s) in Company
1st Dec 20142:39 pmRNSHolding(s) in Company
17th Nov 20147:00 amRNSFurther clinical support for LiDCOrapid
12th Nov 20145:15 pmRNSHolding(s) in Company
7th Nov 201412:03 pmRNSHolding(s) in Company
3rd Nov 20145:49 pmRNSHolding(s) in Company
16th Sep 20147:01 amRNSBoard Announcement
16th Sep 20147:00 amRNSHalf Yearly Report
21st Aug 201411:39 amRNSNotice of Results
18th Aug 20147:00 amRNSTrading update
31st Jul 20141:46 pmRNSBlock Listing Review
30th Jul 20147:00 amRNSFurther clinical support for LiDCO products
11th Jun 201412:45 pmRNSResult of AGM
11th Jun 201411:49 amRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
23rd May 20141:51 pmRNSPosting of Annual Report & Notice of AGM
22nd May 20144:01 pmRNSHolding(s) in Company
21st May 20147:00 amRNSMonitors Link with NantHealth's DeviceConX System
20th May 20147:00 amRNSResults of the OPTIMISE study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.